Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach. Issue 2 (August 2015)

• Record Type: Journal Article
• Authors: Mbanya, Jean Claude; Al-Sifri, Saud; Abdel-Rahim, Aly; Satman, Ilhan
• Is Part Of: Diabetes research and clinical practice. Volume 109:Issue 2(2015)
• Page Start: 226
• Page End: 232
• Publication Date: 2015-08
• Subjects: Diabetes -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462
• DOI: 10.1016/j.diabres.2015.04.030
• Languages: English
• ISSNs: 0168-8227

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Individualized Ramadan-focused advice minimizes risk of hypoglycemic events (HEs).</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Patients taking a DPP-4i or gliclazide when fasting during Ramadan have similarly low risks of HEs.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Randomized-controlled studies are needed to assess OADs and incidence of HEs during Ramadan.</p> </list-item> </list> </p> </sec> </abstract>